Hikma Pharmaceuticals (LSE:HIK) Ending Cash Position : £162 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Hikma Pharmaceuticals Ending Cash Position?

Hikma Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 was £162 Mil.

Hikma Pharmaceuticals's quarterly Ending Cash Position declined from Dec. 2022 (£222 Mil) to Jun. 2023 (£215 Mil) and declined from Jun. 2023 (£215 Mil) to Dec. 2023 (£162 Mil).

Hikma Pharmaceuticals's annual Ending Cash Position declined from Dec. 2021 (£320 Mil) to Dec. 2022 (£222 Mil) and declined from Dec. 2022 (£222 Mil) to Dec. 2023 (£162 Mil).

Hikma Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Hikma Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Ending Cash Position Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

337.25

240.31

320.35

221.67

161.95

Hikma Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															320.35	301.25	221.67	215.42	161.95

Hikma Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hikma Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	111.39	+	50.56
	=	162

Hikma Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	112.97	+	48.98
	=	162

Hikma Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals (LSE:HIK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (LSE:HIK) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HKMPF:USA HIKl:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (LSE:HIK) Headlines

No Headlines